Genomics is transforming modern infectious disease testing and surveillance, and expanding our understanding of pathogen evolution, and antibiotic resistance. In turn, public health professionals are changing the methods they use to research, monitor, and prevent epidemics and pandemics of high-profile infectious diseases such as influenza, tuberculosis, Ebola, and more recently, coronavirus.

In this webcast, the speaker will review the broad applicability of NGS for responding to the SARS-CoV-2 pandemic, from initial detection and characterization of the novel coronavirus to monitoring, surveillance and diagnostic detection. Illumina NGS provides workflow and analysis solutions across the clinical and public health continuum.


  • The value of genomics in the COVID-19 pandemic
  • How NGS can be applied to support surveillance and detection/diagnostic efforts
  • Information NGS can provide versus other conventional methods such as PCR

Kelly Hoon
Infectious Disease Specalist

Date & Time
Nov 10, 2020
9:00 AM - 10:00 AM
North America
Kelly Hoon, Infectious Disease Specialist
Microbial genomics
Watch Now